Evidence map›Paper›PMID 29479305›Full record

ArticleFrontiers in molecular neuroscience2018

Neuronal Growth and Behavioral Alterations in Mice Deficient for the Psychiatric Disease-Associated

Katyayani Singh, Desirée Loreth, Bruno Pöttker, Kyra Hefti, Jürgen Innos, Kathrin Schwald, Heidi Hengstler, Lutz Menzel, Clemens J Sommer, Konstantin Radyushkin and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gut microbes · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.Neurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Katyayani SinghDepartment of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Desirée LorethDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bruno PöttkerDepartment of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Kyra HeftiInstitute of Neuropathology, University Medical Center, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Jürgen InnosDepartment of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Kathrin SchwaldDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Heidi HengstlerDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lutz MenzelDepartment of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
Clemens J SommerInstitute of Neuropathology, University Medical Center, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Konstantin RadyushkinFocus Program Translational Neurosciences, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Oliver KretzDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mari-Anne PhilipsDepartment of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Carola A HaasExperimental Epilepsy Research, Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Katrin FrauenknechtInstitute of Neuropathology, University Medical Center, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Kersti LilleväliDepartment of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Bernd HeimrichDepartment of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Eero VasarDepartment of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Michael K E SchäferDepartment of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
University of Freiburg · DEUniversity of Tartu · EEUniversity Medical Center of the Johannes Gutenberg University Mainz · DEJohannes Gutenberg University Mainz · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal growth regulator 1 (NEGR1), a member of the immunoglobulin superfamily cell adhesion molecule subgroup IgLON, has been implicated in neuronal growth and connectivity. In addition, genetic variants in or near the NEGR1 locus have been associated with obesity and more recently with learning difficulties, intellectual disability and psychiatric disorders. However, experimental evidence is lacking to support a possible link between NEGR1, neuronal growth and behavioral abnormalities. Initial expression analysis of NEGR1 mRNA in C57Bl/6 wildtype (WT) mice by

Indexed as

axon growthcell adhesion moleculecognitionentorhinal cortexhippocampusneuronal connectivitypsychiatric disordersseizures

Identifiers

PMID29479305
PMCPMC5811522
OpenAlexW2793417202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.